David Halen Araújo Pinheiro

Mr. David Halen Araújo Pinheiro

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2023 in Brazilian Journal of Physical Therapy
Verified
Journal Article
Closed access
MKMANUELA KARLOH
MANUELA KARLOH
TMThiago Sousa Matias
Thiago Sousa Matias
JOJoice Mara de Oliveira
Joice Mara de Oliveira
FLFabiano Francisco de Lima
Fabiano Francisco de Lima
DPDavid Halen Araújo Pinheiro
David Halen Araújo Pinheiro
CCCelso R.F. Carvalho
Celso R.F. Carvalho

22 June 2020 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
PDF file
JBJosé Britto-Júnior
José Britto-Júnior
DPDavid Halen Araújo Pinheiro
David Halen Araújo Pinheiro
AJAlberto F. O. Justo
Alberto F. O. Justo
GMGuilherme M. Figueiredo Murari
Guilherme M. Figueiredo Murari
RCRafael Campos
Rafael Campos
GNGilberto De Nucci
Gilberto De Nucci
Electrical field stimulation (EFS) induces contractions of both snake aorta and human umbilical cord vessels (HUCV) which were dependent on the presence of the endothelium. This study aimed to establish the nature of the mediator(s) responsible for EFS‐induced contractions in HUCV. Rings with or without endothelium from human umbilical artery (HUA) or vein (HUV) were mounted in organ bath chambers containing oxygenated, heated Krebs‐Henseleit's solution. Basal release of dopamine (DA), noradrenaline, and adrenaline was measured by LC‐MS‐MS. Cumulative concentration‐response curves were performed with dopamine in the absence and in the presence of L‐NAME or of dopamine antagonists. EFS studies were performed in the presence and absence of L‐NAME, the α‐adrenergic blockers prazosin and idazoxan, and the dopamine antagonists SCH‐23390 and haloperidol. Tyrosine hydroxylase (TH) and dopa‐decarboxylase (DDC) were studied by immunohistochemistry and fluorescence in situ hybridizations. Basal release of dopamine requires an intact endothelium in both HUA and HUV. TH and DDC are present only in the endothelium of both HUA and HUV as determined by immunohistochemistry. Dopamine induced contractions in HUA only in the presence of L‐NAME. Dopamine‐induced contractions in HUV were strongly potentiated by L‐NAME. The EFS‐induced contractions in both HUA and HUV were potentiated by L‐NAME and inhibited by the D2‐like receptor antagonist haloperidol. The α‐adrenergic antagonists prazosin and idazoxan and the D1‐like receptor antagonist SCH‐23390 had no effect on the EFS‐induced contractions of HUA and HUV. Endothelium‐derived dopamine is a major modulator of HUCV reactivity in vitro.

4 June 2024 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
DPDavid Halen Araújo Pinheiro
David Halen Araújo Pinheiro
JSJoao Victor Hermogenes de Souza
Joao Victor Hermogenes de Souza
AJAlberto Fernando Oliveira Justo
Alberto Fernando Oliveira Justo
RCRegina Maria Carvalho-Pinto
Regina Maria Carvalho-Pinto
FLFabiano Francisco de Lima
Fabiano Francisco de Lima
CCCelso R. F. Carvalho
Celso R. F. Carvalho
Objective: To analyze the number of hospitalizations, the length of hospital stay, and mortality due to asthma, as well as the costs to the Unified Health Care System in Brazil between 2008 and 2021. Methods: This was a cross-sectional epidemiological study using data from the Information Technology Department of the Brazilian Unified Health Care System. Proportional hospitalization and death rates were estimated per 100,000 population by age, microregion, and year. Results: The number of hospitalizations and deaths due to asthma decreased from 2008 to 2021 (205,392 vs. 55,009 and 822 vs. 327, respectively). In addition, a between-sex difference was observed in asthma-related hospitalizations in 2008, and more men were hospitalized in 2021 (51.8%). Asthma mortality rates were similar for both sexes (50.0% each) in 2008, and a slight increase was observed in women's deaths in 2021 (52.9%). Even so, approximately one death/day and more than 55,000 hospitalizations were observed yearly, with a mean length of hospital stay of three days. Additionally, the Southeast region allocated more financial resources to asthma-related hospitalizations. Conclusions: Our results showed that the number of deaths and hospitalizations due to asthma substantially declined during the study period.

31 August 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
FLFabiano Francisco de Lima
Fabiano Francisco de Lima
ALAdriana Claudia Lunardi
Adriana Claudia Lunardi
DPDavid Halen Araújo Pinheiro
David Halen Araújo Pinheiro
RCRegina Maria Carvalho-Pinto
Regina Maria Carvalho-Pinto
RSRafael Stelmach
Rafael Stelmach
CCCelso R. F. Carvalho
Celso R. F. Carvalho
Background: Previous research has suggested that most adults improve their asthma control after a short-term behavioral intervention program to increase physical activity in daily life (PADL). However, the characteristics of individuals who respond and do not respond to this intervention and the medium-term response remain unknown. Objective: This study aims to (1) identify the characteristics of adult responders and nonresponders with asthma to a behavioral intervention to increase physical activity and (2) evaluate the functional and clinical benefits in the medium term. Methods: This prospective pragmatic study will include adults with moderate to severe asthma who enroll in a behavioral intervention. All individuals will receive an educational program and an 8-week intervention to increase PADL (1 time/wk; up to 90 min/session). The educational program will be conducted in a class setting through group discussions and video presentations. Behavioral interventions will be based on the transtheoretical model using counseling, incentives, and individual feedback aiming to increase participation in physical activity. Motivational interviewing and guidelines for overcoming barriers will be used to stimulate individuals to reach their goals. Pre- and postintervention assessments will include the following: PADL (triaxial accelerometry), body composition (octopolar bioimpedance), barriers to PADL (questionnaire), clinical asthma control (Asthma Control Questionnaire), quality of life (Asthma Quality of Life Questionnaire), anxiety and depression levels (Hospital Anxiety and Depression Scale), and exacerbations. “Responders” to the intervention will be defined as those who demonstrate an increase in the number of daily steps (≥2500). Results: In December 2021, the clinical trial registration was approved. Recruitment and data collection for the trial is ongoing, and the results of this study are likely to be published in late 2024. Conclusions: The intervention will likely promote different effects according to the clinical characteristics of the individuals, including asthma control, age, anxiety and depression levels, obesity, and several comorbidities. Identifying individuals who respond or do not respond to behavioral interventions to increase PADL will help clinicians prescribe specific interventions to adults with asthma. Trial Registration: ClinicalTrials.gov NCT05159076; https://clinicaltrials.gov/ct2/show/NCT05159076 International Registered Report Identifier (IRRID): DERR1-10.2196/49032

27 February 2025 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
FLFabiano Francisco de Lima
Fabiano Francisco de Lima
JSJuliana de Melo Batista dos Santos
Juliana de Melo Batista dos Santos
RARosana Câmara Agondi
Rosana Câmara Agondi
DPDavid Halen Araújo Pinheiro
David Halen Araújo Pinheiro
YOYan Anderson Pires de Oliveira
Yan Anderson Pires de Oliveira
CCCelso R. F. Carvalho
Celso R. F. Carvalho
Background: Previous studies have shown that increasing physical activity in daily life (PADL) improves asthma clinical control and quality of life. However, the minimal clinically important difference (MCID) to promote those improvements remains unclear. The aim of this study was to estimate the MCID for PADL in people with moderate-to-severe asthma. Methods: Data from consecutive individuals with moderate-to-severe asthma who completed an 8-week (once weekly) face-to-face behavioural intervention to increase PADL were included to compute the MCID. The MCID was estimated based on the number of steps·day−1 and time in moderate-to-vigorous physical activity (MVPA) (min·day−1), which included analyses via anchor-based methods (linear regression and receiver operating characteristic curves) and distribution-based methods (half of the standard deviation and the standard error of the mean). The pooled MCID was estimated by calculating the weighted arithmetic mean of the results from the anchor-based (Asthma Control Questionnaire and Asthma Quality of Life Questionnaire) and distribution-based methods. Results: The MCID estimates for steps·day−1 ranged from 446 to 1995, which were derived from anchor-based and distribution-based methods. With respect to MVPA, MCID estimates ranged from 2 to 13 min·day−1, which were also derived from both methods. The pooled MCIDs were 1413 for steps·day−1 and 8 min·day−1 for MVPA. Conclusion: The MCIDs proposed in this study are 1413 steps for steps·day−1 and 8 min of MVPA per day in people with asthma. These values can be used to interpret the efficacy of intervention programmes to improve health outcomes.

1 January 2020 in Biology Open
Verified
Journal Article
Open access
PDF file
JBJosé Britto-Júnior
José Britto-Júnior
FJFelipe Fernandes Jacintho
Felipe Fernandes Jacintho
RCRafael Campos
Rafael Campos
DPDavid Halen Araújo Pinheiro
David Halen Araújo Pinheiro
GMGuilherme M. Figueiredo Murari
Guilherme M. Figueiredo Murari
GNGilberto De Nucci
Gilberto De Nucci
The contractions of Chelonoidis carbonaria aortic rings induced by electrical field stimulation (EFS) are not inhibited by blockade of the voltage-gated sodium channels by tetrodotoxin but almost abolished by the α1/α2-adrenoceptor antagonist phentolamine. The objective of this study was to identify the mediator(s) responsible for the EFS-induced contractions of Chelonoidis carbonaria aortic rings. Each ring was suspended between two wire hooks and mounted in isolated 10 mL organ chambers filled with oxygenated and heated Krebs-Henseleit's solution. Dopamine, noradrenaline and adrenaline concentrations were analysed by liquid chromatography coupled to tandem mass spectrometry. The contractions caused by dopamine and EFS were done in absence and presence of the nitric oxide (NO) synthesis inhibitor L-NAME, the NO-sensitive guanylyl cyclase inhibitor ODQ, the D1-like receptor antagonist SCH-23390, the D2-like receptor antagonists risperidone, quetiapine, haloperidol, and the tyrosine hydroxylase inhibitors salsolinol and 3-iodo-L-tyrosine. Basal concentrations of dopamine, noradrenaline and adrenaline were detected in Krebs-Henseleit solution containing the aortic rings. The catecholamine concentrations were significantly reduced in endothelium-denuded aortic rings. L-NAME and ODQ significantly potentiated the dopamine-induced contractions. The D2-like receptor antagonists inhibited the EFS-induced contractions of the aortic rings treated with L-NAME, whereas SCH 23390 had no effect. Similar results were observed in the contractions induced by dopamine in L-NAME treated aortic rings. These results indicate that catecholamines released by endothelium regulate the EFS-induced contractions. This may constitute a suitable mechanism by which reptilia modulate specific organ blood flow distribution.